Breaking: White House delays CDC pick. Duties of CDC Director fall to NIH director Jay Bhattacharya, who has been acting cdc director. Me @rachel_roubein@ddiamond
https://t.co/YTwbJAx4PW
Its not just that these aren't the lowest prices anywhere...many companies seem to be strategically only offering "deals" on products where they've abused the system to keep cheaper competitors off market for decades. https://t.co/6CjiyVwUyD
Attributable to a federal health official, this week's ACIP meeting is postponed following the court ruling just now against Sec. Kennedy's overhaul of the federal vaccine schedule and his ACIP appointments.
Amy Abernethy, Co-Founder of Highlander Health, will join Michael McCaughan of Prevision Policy for a Fireside Chat at our upcoming “Application of ECAs in Oncology Drug Development" meeting on April 7. Register today to join in-person or virtually: https://t.co/OYj7PlwF8x.
One year (and change) into @SecKennedy tenure at HHS a lot has changed in the federal approach to immunization. @drJoshS and I break it down.
The 4 Pillars of Childhood Vaccine Policy—1 Year Later https://t.co/ln8HXXrZLv
It’s interesting that @US_FDA chose to redact the entire “path forward” section of the memo. Also, where are the underlining data and any an analyses performed by FDA staff? It’s so irresponsible of @DrMakaryFDA not to put that information into the public. Radical transparency.
More than 3 months after it was publicly reported, too. Strange timing and a reminder that the fatality data still aren't available.
(The full memo, available via BioCentury: https://t.co/2NruoeC7GN)
The FDA commissioner & his CBER director are breaking the law. Under GOP gavels, the Energy & Commerce Committee has done nothing to stop it. The simple first step is a hearing.
On Prasad’s last few weeks as CBER chief:
1. It was absurdly inappropriate to bring a large group of reporters together and rail on a pending application “on background”
2. The walk back of the Moderna RTF was a bad unforced error. He could’ve just overruled staff again, following a review
3. Fingers crossed he comes back to Twitter
This 'senior official' was Vinay Prasad. Disclosing trade secret information without legal authorization is a prohibited act under the FDCA & a criminal violation under the Trade Secrets Act.
Impt thread that describes the real world challenges of this new vaccine schedule—challenges that @hhs didn’t consider in their closed door process —at least they aren’t referenced in any of the docs released today. Sad.
As a doctor who treated patients for decades, my top priority is protecting children and families. Multiple children have died or were hospitalized from measles, and South Carolina continues to face a growing outbreak. Two children have died in my state from whooping cough. All of this was preventable with safe and effective vaccines.
The vaccine schedule IS NOT A MANDATE. It’s a recommendation giving parents the power. Changing the pediatric vaccine schedule based on no scientific input on safety risks and little transparency will cause unnecessary fear for patients and doctors, and will make America sicker.
FDA appears to have named Angelo de Claro as the new Acting Director of its Oncology Center of Excellence.
Marks the first time the center has ever been led by anyone other than Rick Pazdur.
It's still not clear if de Claro will lead it long term.
https://t.co/6T0GNfFuup